Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks
Prompte und intensive antivirale Chemoprophylaxe bei Influenzaausbrüchen in Pflegeheimen
JAMA Internal Medicine · 01.06.2026 · 186 (6) · 714
DOI: 10.1001/jamainternmed.2026.0401 ↗Auf einen Blick
Bei 404 Ausbrüchen in 318 Pflegeheimen war intensive Oseltamivir-Prophylaxe mit weniger Hospitalisierungen nach 14 Tagen verbunden, aber nicht mit weniger Todesfällen.
Fragestellung
Ist der Beginn einer antiviralen Chemoprophylaxe bei 70 % oder mehr der geeigneten Pflegeheimbewohner:innen innerhalb von 2 Tagen nach Ausbruchserkennung mit weniger Mortalität und Hospitalisierung nach 14 und 30 Tagen verbunden?
Methode
Retrospektive Kohortenstudie mit Sequential Cluster-Randomized Target Trial Emulation und Randomize-Censor-Weight-Verfahren in 12 US-Pflegeheim-Konzernen; Datenanalyse Februar 2023 bis Januar 2026.
Ergebnisse
Bei 14 Tagen betrug die RD für Tod –0,06 % (95 %-KI −0,73 % bis 0,93 %; RR 0,96, 95 %-KI 0,56–1,57) und für Hospitalisierung –0,96 % (95 %-KI −1,78 % bis −0,19 %; RR 0,79, 95 %-KI 0,64–0,96).
Schlussfolgerung der Autor:innen
Die Autor:innen schließen, dass Kliniker die antivirale Chemoprophylaxe bei mindestens 70 % der geeigneten Pflegeheimbewohner:innen innerhalb von 2 Tagen nach Ausbruchserkennung beginnen sollten, um das Hospitalisierungsrisiko zu senken.
Kernaussagen
- Intensive Oseltamivir-Prophylaxe senkte nach 14 Tagen Hospitalisierungen.
- Kein Unterschied bei Todesfällen nach 14 Tagen.
- Nach 30 Tagen blieben die Hospitalisierungsunterschiede bestehen, aber unpräziser.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift JAMA Internal Medicine, erschienen am 01.06.2026. Verfasst von Joe B B Silva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island. Hauptthemen laut MEDLINE: Influenza, Human, Antiviral Agents, Disease Outbreaks, Oseltamivir. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Themen: Langzeitpflege
Abstract (Originalsprache)
Importance Influenza outbreaks in nursing homes (NHs) can cause high morbidity and mortality. Antiviral chemoprophylaxis with oseltamivir is recommended, yet optimal implementation strategies remain unclear.
Objective
To examine whether initiating antiviral chemoprophylaxis for 70% or more of eligible NH residents within 2 days of influenza outbreak detection is associated with lower all-cause mortality and hospitalization at 14 and 30 days. Design, Setting, and Participants Retrospective cohort study using a sequential cluster-randomized target trial emulation and randomize-censor-weight approach for influenza outbreaks (September 1, 2018–May 31, 2022) in 12 US NH corporations. Eligibility criteria were age 18 years or older, present on the outbreak-detection day, no antiviral use in the preceding 7 days, no influenza in the past 14 days, and complete baseline data. Residents were followed up until hospitalization or death, an NH discharge to a nonacute-care location, or the end of follow-up. Data were analyzed from February 2023 to January 2026. Exposures Intensive antiviral chemoprophylaxis with oseltamivir (≥70% of eligible residents within 2 days of outbreak detection) or nonintensive antiviral chemoprophylaxis (0% to <70% of eligible residents). Main Outcomes and Measures Outcomes were all-cause death and hospitalizations within 14 and 30 days of outbreak detection. Discrete-time hazard models with pooled logistic regression were applied to estimate weighted risks, risk differences (RDs), and risk ratios (RRs).
Results
Among 404 outbreaks in 318 NHs, 35 086 resident-trial observations (29 683 residents; median age 78 [IQR, 68- 86] years; 60% women; 81% White; 76% vaccinated) met eligibility criteria. Intensive oseltamivir prophylaxis was randomized to 17 155 observations; 17 931 were randomized to nonintensive care. At 14 days, intensive prophylaxis vs nonintensive yielded an RD of –0.06% (95% CI, −0.73% to 0.93%) and an RR of 0.96 (95% CI, 0.56-1.57) for death, and an RD of –0.96% (95% CI, −1.78% to −0.19%) and an RR of 0.79 (95% CI, 0.64-0.96) for hospitalization. At 30 days, the hospitalization differences persisted but were less precise and there continued to be no difference in death. Conclusions and Relevance Study results suggest that clinicians should initiate antiviral chemoprophylaxis for at least 70% of eligible NH residents within 2 days of outbreak detection to lower risk of hospitalization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island.
- Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island.
- Center for Epidemiologic Research, Brown University School of Public Health, Providence, Rhode Island.
- Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts.
- Division of Geriatrics and Palliative Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
- Providence Veterans Affairs Medical Center, Providence, Rhode Island.
Förderung
- NIA NIH HHS
Zitieren
APA
Silva, J. B. B., Hsieh, H. T., Howe, C. J., Gravenstein, S., Reich, L. A., & Zullo, A. R. (2026). Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks. JAMA Internal Medicine, 186(6), 714. https://doi.org/10.1001/jamainternmed.2026.0401
Vancouver
Silva JBB, Hsieh HT, Howe CJ, Gravenstein S, Reich LA, Zullo AR. Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks. JAMA Internal Medicine. 2026;186(6):714. doi:10.1001/jamainternmed.2026.0401
BibTeX
@article{Silva2026,
author = {Silva, Joe B B and Hsieh, Han-Chih T and Howe, Chanelle J and Gravenstein, Stefan and Reich, Laura A and Zullo, Andrew R},
title = {Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks},
journal = {JAMA Internal Medicine},
year = {2026},
volume = {186},
number = {6},
pages = {714},
doi = {10.1001/jamainternmed.2026.0401}
}
EUVIMED